We describe a case of recurrent Scopulariopsis brevicaulis subcutaneous infection, which occurred 6 years after the patient underwent liver transplantation. Combined surgery and long-term oral therapy with terbinafine resulted in a favorable outcome, although this is not the rule in the previously reported S. brevicaulis infections in immunocompromised patients.
. Recurrent red-wine colored, exophytic, ulcerative subcutaneous lesion on the left forearm of a liver transplant recipient; the lesion was due to Scopulariopsis brevicaulis. portunistic agent in immunocompromised patients, in whom few cases of fatal systemic infections have been described. We describe a case of recurrent subcutaneous infection due to S. brevicaulis in a liver transplant recipient for whom the outcome was favorable.
A 61-year-old man was admitted to the hospital for treatment of a third episode of S. brevicaulis subcutaneous infection. His medical history was marked by liver transplantation for primary biliary cirrhosis in March 1990. His immunosuppressive therapy consisted of a combination of cyclosporine, azathioprine, and prednisone. Subsequently, the initial dosage of steroids (1 mg/kg/d) was progressively decreased during the 3 years after transplantation, to a plateau of 12 mg of prednisone daily. In March 1993, the patient was totally asymptomatic, and cyclosporine was replaced by tacrolimus .
At the beginning of 1996, a skin tumor the color of red wine on his left forearm was surgically removed. Histological analysis of tissue sections showed an inflammatory dermic granuloma. Microabscesses with polymorphonuclear neutrophil leukocytes and many very long hyphae were seen. Skin culture yielded S. brevicaulis. Therapy with itraconazole was started but was spontaneously discontinued by the patient 3 days later. Nevertheless, the postoperative wound remained free of infection for 7 months. In February 1997, a new large (2.5 cm) exophytic, ulcerative skin tumor appeared on the patient's right ankle, which was also surgically removed. Histological examination of the material showed a dermic inflammatory infiltrate with wide, frequently septate, and dichotomously branched hyaline hyphae. Unfortunately, no skin culture was performed. Treatment with itraconazole was begun but was stopped 10 days later because of a dramatic increase in blood levels of tacrolimus. However, this lesion on the ankle also healed without any further treatment.
In May 1997, the left forearm skin tumor relapsed at the same place as in 1996 (figure 1). Numerous hyphae were found during repeated surgical biopsy. Skin culture yielded S. brevicaulis again. In vitro antifungal susceptibility testing (ATBFungus; bioMérieux SA, Marcy l'Etoile, France) showed resistance to amphotericin B, flucytosine, itraconazole (Etest [AB BIODISK, Solna, Sweden] revealed an itraconazole MIC 124 mg/mL), and miconazole, and intermediate susceptibility to ketoconazole, econazole, and nystatin. The patient was referred to the department of internal medicine for therapeutic evaluation. The clinical events and treatments for this patient are summarized in table 1.
Physical examination revealed that the tumor was the color of red wine, recently flattened, exophytic and ulcerative, and not associated with any pain or itching. No lymphadenopathy or hepatosplenomegaly was found. The patient was not febrile. The abdomen was painless without ascites. Mild jaundice was noted. There was no cardiac murmur; the lungs were clear, and results of neurological examination were normal. Performance status was normal, and his weight was stable.
Ophthalmologic examination did not reveal any signs of fungal infection. MRI of the soft tissues of the left forearm showed extension of the cutaneous lesion (thickness, 5 mm; diameter, 5 cm) without muscle or bone infiltration. Six fungal cultures remained negative.
Laboratory studies of blood showed mild neutrophilia (neutrophil count, 5300/mm 3 ) and an erythrocyte sedimentation rate of 50 mm/h. Liver function tests disclosed the following values: total bilirubin, 24 mmol/L; direct bilirubin, 11 mmol/L; aspartate aminotransferase, 159 U/L; alanine aminotransferase, 222 U/ L; and alkaline phosphatase, 166 U/L. The blood glucose level was 21 mmol/L, which was associated with glycosuria (urine levels of glucose reached 250 mmol daily). There was mild renal insufficiency; this finding appeared to be stable when compared with previous data (serum urea level, 9.8 mmol/L; creatinine level, 123 mmol/L). Blood tests for HIV and hepatitis C virus were negative.
A chest radiogram was normal. Two-dimensional transesophageal echocardiography did not show valvular vegetations or abscess. Ultrasonography and CT of the abdomen were unremarkable. Transcutaneous liver biopsy showed only signs of mild chronic rejection. Therefore, the immunosuppressive regimen was not changed, and a progressive decrease in transaminase levels was observed. Diabetes mellitus was treated with subcutaneous insulin.
In preparation for surgical ablation of the cutaneous lesion, amphotericin B treatment was started 3 days before the operation: the dosage was gradually increased from 0.5 mg/kg/d to 0.8 mg/kg/d (50 mg/d). Administration of this drug was continued for 1 week, despite in vitro resistance. This treatment was then changed to oral terbinafine (250 mg daily), which was associated with sequential control of blood levels of tacrolimus. Skin grafting was done at the time of surgical excision. The subsequent clinical outcome was favorable, with complete healing of the skin wound. Liver enzyme levels returned to normal values.
Terbinafine treatment was maintained at the same dosage (250 mg daily) and 2 years later remained well tolerated. At the time of this report, the patient was well, and there had been no further recurrence.
Discussion. In immunocompetent patients, S. brevicaulis (a fungus found in soil) may cause onychomycosis, accounting for ∼1%-10% of such infections [2] . Rarely, it may be responsible for cutaneous lesions [3] [4] [5] [6] or more severe infections, especially after traumatic or surgical injuries [7] [8] [9] [10] [11] (table 2) . Opportunistic infections may also occur in immunocompromised patients [5] , including localized infections that occur after various traumatic or surgical injuries [8] [9] [10] and invasive tissue disease and/or disseminated infections [12] [13] [14] [15] [16] that are associated with a very poor outcome (table 2) .
The present case focuses on a patient in whom several subcutaneous recurrences occurred at 2 different sites. The multifocal nature of this soft-tissue involvement suggests the possibility of either multifocal inoculation or, more likely, hematogenous dissemination with soft-tissue localization. However, the true mechanism could not be ascertained, despite a negative fungal blood culture, because of the poor sensitivity of blood cultures for identification of the organism. In contrast with most previously described immunocompromised patients infected with S. brevicaulis, the outcome for our patient was favorable after the third lesion was surgically removed and long-term therapy with oral terbinafine was maintained.
Therapy for S. brevicaulis infection remains difficult, especially for immunocompromised patients, because of multiple drug interactions [17] [18] [19] . In addition, only a few studies on therapy for such patients have been reported [12] [13] [14] [15] [16] , of which only 1 reported success [14] . Prolonged intravascular catheterization, vascular grafting, repeated punctures with large bore needles, and decreased immune defense mechanism make uremic patients undergoing hemodialysis more likely to develop Staphylococcus aureus bacteremia and its complications [1] . The complications usually include infective endocarditis, osteomyelitis, septic arthritis, metastatic abscess, pulmonary emboli, pleural empyema, meningitis, and local vascular access problems [2] , but not mycotic aneurysm of the abdominal aorta.
A 76-year-old male nonsmoker who had been undergoing hemodialysis for 7 years because of diabetic nephropathy was admitted to the hospital because of fever and chills for 2 weeks. Physical findings were unremarkable, except for anemic conjunctiva and painful reddish swelling of the right forearm and neck region. Laboratory studies disclosed the following values: blood urea nitrogen, 81 mg/dL (normal range, 7-22 mg/dL); creatinine, 8.7 mg/dL (normal range, 0.7-1.5 mg/dL); and ferritin, 997 mg/dL (normal range, 100-300 mg/dL). The WBC , with 3% band forms, 87% neutrophils, and 5% lymphocytes. After admission, 3 sets of blood cultures were performed, and therapy with iv oxacillin sodium (2 g q6h daily) was started.
The temporary double-lumen catheter in the right internal jugular vein and the infected arteriovenous graft were removed. The catheter tip was sent for culture. Unfortunately, all the blood cultures and the catheter tip culture yielded methicillinresistant S. aureus (MRSA). Antibiotic therapy was changed to iv vancomycin (1 g once weekly after a 1 g bolus dose). The trough level of vancomycin was 14.38 mg/dL (therapeutic range, 5-15 mg/dL). After 6 weeks of iv vancomycin therapy, he was discharged with a femoral catheter. However, fever relapsed 2 days later. Cultures of blood and the catheter tip were again positive for MRSA.
He was again treated with iv vancomycin (1 g once weekly) plus oral rifampin (300 mg b.i.d. for 2 weeks). He was discharged in a rather stable condition except for a hearing problem due to ototoxicity from vancomycin. Unfortunately, he was readmitted the next day for abdominal pain and fever. Intravenous teicoplanin (500 mg 3 times per week) and oral rifampin (300 mg b.i.d.) were given to avoid further ototoxicity from vancomycin. Three sets of blood culture that were positive for MRSA were performed. Abdominal CT revealed an aneurysm around the suprarenal abdominal aorta. Under the guidance of sonography, pus was aspirated from the aneurysm, and culture of the pus yielded MRSA.
Although treatment with teicoplanin and rifampin was given, fever persisted (temperature, ∼38ЊC-39ЊC). Repeated blood cultures yielded MRSA. Another abdominal CT scan revealed disruption of the mural calcification of the abdominal aorta with progressive enlargement of a ruptured segmental mycotic aneurysm (figure 1). The patient died 4 months after the first episode of S. aureus bacteremia.
In this case, S. aureus bacteremia was believed to result from local colonization of skin around the catheter or infection of skin at the catheter insertion site [3] . It is curious that S. aureus may cause suprarenal aortic mycotic aneurysm in a patient undergoing hemodialysis. Only 37 cases of suprarenal aortic mycotic aneurysm have been reported in the past 36 years, all of which occurred in nonuremic patients, except 1 in a patient
